Latest news
Prioritised use cases: drug synergies and COVID-19
🔧 PerMedCoE has prioritised two of the five use cases designed to test its core applications: the study of drug synergies and the study of COVID-19.
PerMedCoE poster at PRACEdays21
📽️ 23 March 2021 – Recording of poster presentation about the COVID-19 Modelling use case presented at PRACEdays21 is available online!
PerMedCoE participates in PATC training
📽 Recording of PerMedCoE’s session at the PATC-CompBioMed short course on HPC-based Computational Bio-Medicine is now available!
Trainings, webinars & courses
Webinar: Data protection and security aspects of running simulations on personal data with HPC
👩🏾💻 Watch the recorded webinar now on our YouTube channel!
Virtual course: Drug studies in signalling pathways models and their integration into multiscale models
22 – 23 June 2022. This course introduces tools to study drug treatments in intracellular signalling pathways and in cell populations
PerMedCoE summer school: from pathway modelling tools to cell-level simulations
👩🏾💻 25-30 June 2023 – PerMedCoE Summer School on Cell-level Simulations
Discover PerMedCoE ZENODO Community
Click HereOptimising cell-level
simulation software
to run in pre-exascale
platforms
Use cases driving the
implementation of
PerMed solutions in
HPC/Exascale
environment
Integrating PerMed
communities into
the new European
HPC/Exascale
ecosystem
Training biomedical
professionals in the
use of HPC/Exascale
PerMed tools
Building the basis
for the sustainability
of the PerMedCoE